U.S. market Closed. Opens in 17 hours 3 minutes

EWTX | Edgewise Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue1.73M538.00K272.00K185.00K123.00K
Gross Profit-1.73M-538.00K-272.00K-185.00K-123.00K
Operating Expenses112.62M22.08M43.22M17.19M9.92M
Selling, General & Admin23.27M5.47M11.03M2.21M1.30M
Research & Development89.35M16.61M32.19M14.98M8.62M
Other Operating ExpensesN/AN/AN/AN/AN/A
Operating Income-114.36M-22.08M-43.22M-17.19M-9.92M
Other Expenses / Income14.19M2.66M402.00K69.00K219.00K
Before Tax Income-100.16M-19.41M-42.81M-17.12M-9.71M
Income Tax ExpensesN/A-4.02M-674.00K-69.00K-219.00K
Net Income-100.16M-15.40M-42.14M-17.05M-9.49M
Interest ExpensesN/A4.02MN/AN/AN/A
Basic Shares Outstanding63.72M53.59M49.50M49.22M49.22M
Diluted Shares Outstanding63.72M53.59M49.50M49.22M49.22M
EBITDA-112.62M-22.08M-43.22M-17.01M-9.80M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-100.16M-15.40M-42.81M-17.12M-9.71M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙